Match!
Mireille M Goetghebeur
Université de Montréal
51Publications
16H-index
1,080Citations
Publications 54
Newest
Source
Source
Source
Background Multiple technologies, procedures and programs call for fairly-based decisions for prioritization of healthcare interventions. There is a diversity of perspectives of what constitutes a legitimate decision, which depends on both the process and the reasoning applied. Current approaches focus on technical aspects while methods to support alignment of decisions with the compassionate impetus of healthcare systems is lacking.
2 CitationsSource
Source
#1Monika Wagner (Analytica)H-Index: 18
#2H Khoury (Analytica)H-Index: 7
Last.Mireille M Goetghebeur (UdeM: Université de Montréal)H-Index: 16
view all 7 authors...
The objective of the study was to reveal through pragmatic MCDA (EVIDEM) the contribution of a broad range of criteria to the value of the orphan drug lenvatinib for radioiodine refractory differentiated thyroid cancer (RR-DTC) in country-specific contexts. The study was designed to enable comprehensive appraisal (12 quantitative, 7 qualitative criteria) in the current disease context (watchful waiting, sorafenib) of France, Italy and Spain. Data on the value of lenvatinib was collected from div...
13 CitationsSource
#1Monika Wagner (Analytica)H-Index: 18
#2D Samaha (Analytica)H-Index: 2
Last.Mireille M Goetghebeur (UdeM: Université de Montréal)H-Index: 16
view all 8 authors...
Source
#1Monika Wagner (Analytica)H-Index: 18
#2D Samaha (Analytica)H-Index: 2
Last.Mireille M Goetghebeur (UdeM: Université de Montréal)H-Index: 16
view all 13 authors...
Source
#1Mireille M Goetghebeur (UdeM: Université de Montréal)H-Index: 16
Last.Norman Daniels (Harvard University)H-Index: 44
view all 4 authors...
8 CitationsSource
#1Monika Wagner (Analytica)H-Index: 18
#2Mireille M Goetghebeur (UdeM: Université de Montréal)H-Index: 16
Source
123456